FDA.reportPublic FDA data

ELVITEGRAVIR

Substance profile for UNII 4GDQ854U53, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ELVITEGRAVIR
Structure render from PubChem CID 5277135

Substance Identity#

UNII
4GDQ854U53
Preferred term
ELVITEGRAVIR
Registry number
697761-98-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C23H23ClFNO5
Chemical structure for ELVITEGRAVIR
Structure render from PubChem CID 5277135

Chemical And Database Identifiers#

InChIKey
JUZYLCPPVHEVSV-LJQANCHMSA-N
SMILES
COC1=CC2=C(C=C1CC3=CC=CC(Cl)=C3F)C(=O)C(=CN2[C@H](CO)C(C)C)C(O)=O
RxCUI
1306286
PubChem
5277135
NCIt
C76493
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound5277135https://pubchem.ncbi.nlm.nih.gov/compound/5277135
PubChem InChIKey SearchJUZYLCPPVHEVSV-LJQANCHMSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=JUZYLCPPVHEVSV-LJQANCHMSA-N
RxNorm1306286https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1306286
NCI ThesaurusC76493https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C76493
FDA Substance Registration System4GDQ854U53https://precision.fda.gov/uniisearch/srs/unii/4GDQ854U53

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ELVITEGRAVIRACTIVE MOIETY4GDQ854U53These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20121
ELVITEGRAVIRACTIVE INGREDIENT4GDQ854U53These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20121
elvitegravirACTIVE MOIETY4GDQ854U53STRIBILD (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]7
elvitegravirACTIVE INGREDIENT4GDQ854U53STRIBILD (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]7
elvitegravirACTIVE INGREDIENT4GDQ854U53STRIBILD ACCESS (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]2
elvitegravirACTIVE MOIETY4GDQ854U53STRIBILD ACCESS (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]2
ELVITEGRAVIRACTIVE MOIETY4GDQ854U53VITEKTA (ELVITEGRAVIR) TABLET, FILM COATED [GILEAD SCIENCES, INC.]2
ELVITEGRAVIRACTIVE INGREDIENT4GDQ854U53VITEKTA (ELVITEGRAVIR) TABLET, FILM COATED [GILEAD SCIENCES, INC.]2
elvitegravirACTIVE INGREDIENT4GDQ854U53GENVOYA (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE) TABLET [GILEAD SCIENCES, INC.]1
elvitegravirACTIVE MOIETY4GDQ854U53GENVOYA (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE) TABLET [GILEAD SCIENCES, INC.]1